Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia
- 1 October 2005
- journal article
- research article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 78 (1), 45-60
- https://doi.org/10.1016/j.schres.2005.05.009
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of d-cycloserinePsychiatry Research: Neuroimaging, 2005
- Cerebral D2 and 5-HT2 Receptor occupancy in Schizophrenic Patients Treated with Olanzapine Or ClozapineJournal of Psychopharmacology, 2004
- Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In VivoNeuropsychopharmacology, 2002
- Test-Retest Reliability of a Functional MRI Working Memory Paradigm in Normal and Schizophrenic SubjectsAmerican Journal of Psychiatry, 2001
- Preliminary Evidence of Improved Verbal Working Memory Performance and Normalization of Task-Related Frontal Lobe Activation in Schizophrenia Following Cognitive ExercisesAmerican Journal of Psychiatry, 2000
- Functional brain imaging and aging in schizophreniaSchizophrenia Research, 1997
- Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenicsThe Lancet, 1997
- On Localizing Schizophrenic NeuropathologySchizophrenia Bulletin, 1997
- Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patientsPsychiatry Research: Neuroimaging, 1996
- PET-FDG Test-Retest Reliability During a Visual Discrimination Task in SchizophreniaJournal of Computer Assisted Tomography, 1993